Single Center Clinical Experience With Radium-223 Dichloride In Patients With Metastatic Castrate-resistant Prostate Cancer

被引：0
|
作者：
Tiskevicius, S. [1 ]
Vidrinskaite, A. [1 ]
Stalnionis, M. [1 ]
机构：
[1] Natl Canc Inst, Vilnius, Lithuania
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0683
引用
收藏
页码：S572 / S572
页数：1
相关论文
共 50 条
  • [31] Metastatic castration resistant prostate cancer patients' experience with Radium-223 treatment in Japan
    Akakura, Koichiro
    Uemura, Hiroji
    Kawakami, Satoru
    Yokomizo, Akira
    Nakamura, Motonobu
    Nishimura, Kazuo
    Komori, Tetsushi
    Ledesma, Dianne Athene
    [J]. FUTURE ONCOLOGY, 2024, 20 (12) : 781 - 798
  • [32] Seven Years of Clinical Experience Outcome Review on Radium 223 Therapy In Bone Metastatic Castrate-resistant Prostate Cancer (mCRPC)
    Cantinho-Lopes, M.
    Pena, H.
    Filipe, P.
    Mansinho, A.
    Fernandes, I.
    Costa, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S400 - S400
  • [33] Radium-223 in metastatic castration resistant prostate cancer
    Vuong, Winston
    Sartor, Oliver
    Pal, Sumanta K.
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2014, 16 (03) : 348 - 353
  • [34] Initial post-approval clinical experience with Radium-223 dichloride in patients with prostate cancer
    Conti, Peter
    Challa, Sudha
    Jadvar, Hossein
    Pinski, Jacek
    Gross, Mitchell
    Dorff, Tanya
    Quinn, David
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [35] Survival and fracture risk with radium-223 therapy in metastatic castrate-resistant prostate cancer (mCRPC): A real-world analysis
    Zhang, Hanbo
    Graham, Jeffrey
    Czaykowski, Piotr
    Gingerich, Joel Roger
    Bybel, Bohdan
    Dawe, David E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 50 - 50
  • [36] The effect of docetaxel, enzalutamide, abiraterone, and radium-223 on cognitive function in older men with metastatic castrate-resistant prostate cancer (mCRPC)
    Alibhai, Shabbir M. H.
    Breunis, Henriette
    Timilshina, Narhari
    Hansen, Aaron Richard
    Joshua, Anthony M.
    Warde, Padraig Richard
    Gregg, Richard William
    Fleshner, Neil Eric
    Tomlinson, George
    Hotte, Sebastien J.
    Emmenegger, Urban
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [37] Patterns of response and progression in bone and soft tissue during and after treatment with radium-223 for metastatic castrate-resistant prostate cancer
    McNamara, Megan Ann
    Oyekunle, Taofik
    Chin, Bennett B.
    Oldan, Jorge
    Anand, Aseem
    Ritz, Michala
    Shantzer, Lindsey
    Anand, Monika
    Armstrong, Andrew J.
    George, Daniel J.
    [J]. PROSTATE, 2019, 79 (10): : 1106 - 1116
  • [38] Residents' Guide to Radium-223 Dichloride Treatment For Metastatic Prostate Cancer
    Ersahin, Devrim
    Chen, Ming-Kai
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [39] Radium-223 Dichloride for Metastatic Castration-resistant Prostate Cancer: The Urologist's Perspective
    Shore, Neal D.
    [J]. UROLOGY, 2015, 85 (04) : 717 - 724
  • [40] Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer
    Kuppen, Malou C. P.
    Westgeest, Hans M.
    van der Doelen, Maarten J.
    van den Eertwegh, Alphonsus J. M.
    Coenen, Jules L. L. M.
    Aben, Katja K. H.
    van den Bergh, Alphons C. M.
    Bergman, Andries M.
    van den Bosch, Joan
    Celik, Filiz
    Hendriks, Mathijs P.
    Lavalaye, Jules
    van der Meer, Saskia
    Polee, Marco B.
    Somford, Diederik M.
    van Oort, Inge M.
    Uyl-de Groot, Carin A.
    Gerritsen, Winald R.
    [J]. FUTURE ONCOLOGY, 2020, 16 (19) : 1371 - 1384
12345